Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jeffrey Montgomery

Concepts (437)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder Neoplasms
52
2024
165
9.500
 Why?
Cystectomy
31
2024
51
6.090
 Why?
Prostatic Neoplasms
43
2024
398
4.930
 Why?
Kidney Neoplasms
22
2018
182
2.670
 Why?
Carcinoma, Transitional Cell
13
2023
54
2.600
 Why?
Prostatectomy
22
2023
84
2.290
 Why?
Nephrectomy
19
2016
82
1.930
 Why?
Lymph Node Excision
7
2024
133
1.770
 Why?
Urinary Diversion
6
2021
43
1.590
 Why?
Prostate
14
2024
116
1.500
 Why?
Laparoscopy
13
2014
180
1.490
 Why?
Quality of Life
12
2023
879
1.410
 Why?
Aged
81
2024
10121
1.280
 Why?
Male
120
2024
26761
1.200
 Why?
Middle Aged
87
2024
13028
1.140
 Why?
Humans
149
2024
52483
1.130
 Why?
Neoadjuvant Therapy
12
2024
125
1.100
 Why?
Neoplasm Staging
25
2024
772
0.990
 Why?
BCG Vaccine
7
2024
16
0.950
 Why?
Robotics
8
2015
43
0.940
 Why?
Postoperative Complications
15
2021
1068
0.890
 Why?
Retrospective Studies
52
2024
6607
0.880
 Why?
Carcinoma, Renal Cell
10
2016
111
0.870
 Why?
Penile Neoplasms
3
2024
44
0.860
 Why?
Exercise Therapy
1
2023
100
0.800
 Why?
Ureter
3
2016
36
0.790
 Why?
Exercise
2
2023
547
0.770
 Why?
Hernia
2
2020
7
0.750
 Why?
Intestine, Small
2
2020
115
0.690
 Why?
Neoplasm Recurrence, Local
15
2024
649
0.690
 Why?
Physical Fitness
1
2020
57
0.670
 Why?
Treatment Outcome
30
2024
5422
0.670
 Why?
Herniorrhaphy
1
2020
33
0.670
 Why?
Intestinal Obstruction
1
2020
38
0.660
 Why?
Patient Readmission
6
2021
246
0.650
 Why?
Image-Guided Biopsy
6
2024
34
0.640
 Why?
Aged, 80 and over
26
2024
3392
0.630
 Why?
Watchful Waiting
7
2019
28
0.620
 Why?
Biopsy
17
2023
605
0.590
 Why?
Ureteral Neoplasms
2
2018
11
0.590
 Why?
Neoplasm Invasiveness
14
2024
278
0.590
 Why?
Female
59
2024
28171
0.550
 Why?
Testicular Neoplasms
4
2024
46
0.540
 Why?
Magnetic Resonance Imaging
10
2023
1546
0.530
 Why?
Urinary Bladder
7
2018
101
0.530
 Why?
Convalescence
1
2016
6
0.520
 Why?
Carcinoma, Squamous Cell
4
2024
332
0.510
 Why?
Neoplasms, Germ Cell and Embryonal
3
2024
20
0.490
 Why?
Urothelium
4
2018
19
0.470
 Why?
Prospective Studies
17
2024
2481
0.470
 Why?
Carcinoma in Situ
4
2024
72
0.470
 Why?
Chemotherapy, Adjuvant
8
2024
124
0.470
 Why?
Ileum
1
2014
88
0.450
 Why?
Urologic Neoplasms
3
2019
12
0.450
 Why?
Choline
3
2019
64
0.440
 Why?
Neoplasm Grading
13
2020
126
0.440
 Why?
Medical Oncology
4
2021
104
0.430
 Why?
Quality Indicators, Health Care
1
2013
90
0.390
 Why?
Needles
3
2021
25
0.390
 Why?
Administration, Intravesical
7
2024
16
0.380
 Why?
Urologic Surgical Procedures
3
2016
30
0.380
 Why?
Disease Progression
8
2024
871
0.370
 Why?
Lymphatic Metastasis
4
2024
220
0.370
 Why?
Antineoplastic Agents
3
2021
1222
0.370
 Why?
Biopsy, Needle
5
2021
183
0.360
 Why?
Prostate-Specific Antigen
8
2021
44
0.360
 Why?
Survival Rate
9
2021
945
0.360
 Why?
Testicular Diseases
1
2011
10
0.350
 Why?
Risk Assessment
10
2019
1327
0.350
 Why?
Urogenital Neoplasms
1
2010
9
0.350
 Why?
Tumor Burden
6
2016
136
0.350
 Why?
Muscle Neoplasms
1
2010
16
0.340
 Why?
Magnetic Resonance Imaging, Interventional
4
2024
5
0.340
 Why?
Registries
4
2023
581
0.330
 Why?
Fluorine Radioisotopes
2
2019
25
0.320
 Why?
Retroperitoneal Space
5
2016
26
0.320
 Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
1031
0.320
 Why?
Recovery of Function
2
2023
199
0.320
 Why?
Adult
27
2024
14161
0.310
 Why?
Psoas Muscles
2
2021
2
0.310
 Why?
Self Report
1
2010
210
0.310
 Why?
Organ Sparing Treatments
4
2018
57
0.310
 Why?
Telomerase
2
2019
26
0.300
 Why?
Patient Selection
5
2019
259
0.300
 Why?
Urinary Incontinence
3
2023
40
0.290
 Why?
Deoxycytidine
3
2024
29
0.280
 Why?
Seat Belts
2
2017
17
0.280
 Why?
Child Restraint Systems
2
2017
18
0.280
 Why?
Urinary Catheterization
1
2007
24
0.280
 Why?
Urethral Stricture
1
2007
23
0.280
 Why?
Positron-Emission Tomography
2
2019
301
0.280
 Why?
Time Factors
13
2020
2968
0.270
 Why?
Primary Health Care
1
2011
376
0.270
 Why?
Rectum
2
2024
55
0.270
 Why?
Cohort Studies
8
2021
1542
0.260
 Why?
Tomography, X-Ray Computed
3
2021
1165
0.260
 Why?
Guideline Adherence
3
2017
138
0.260
 Why?
Length of Stay
6
2020
663
0.260
 Why?
Health Status
2
2015
294
0.250
 Why?
Pain Measurement
2
2017
256
0.250
 Why?
Patient Discharge
3
2017
330
0.250
 Why?
Patient Participation
2
2016
69
0.240
 Why?
Kidney
4
2014
707
0.240
 Why?
Bandages
1
2005
28
0.230
 Why?
Carcinoma
2
2018
138
0.230
 Why?
Adenoviridae
2
2024
47
0.230
 Why?
Surgical Wound Infection
1
2005
118
0.230
 Why?
Neurilemmoma
1
2004
24
0.230
 Why?
Antimetabolites, Antineoplastic
1
2024
39
0.230
 Why?
Multivariate Analysis
8
2016
591
0.230
 Why?
Age Factors
7
2021
1132
0.220
 Why?
Quality Improvement
3
2016
226
0.220
 Why?
Immunohistochemistry
5
2024
979
0.220
 Why?
Adenocarcinoma
3
2016
405
0.220
 Why?
Organoids
1
2024
39
0.220
 Why?
Venous Thrombosis
1
2005
90
0.220
 Why?
Perineum
1
2024
26
0.220
 Why?
Follow-Up Studies
9
2024
2279
0.220
 Why?
Antibiotic Prophylaxis
1
2024
61
0.210
 Why?
Decision Making
2
2016
282
0.210
 Why?
Clinical Competence
3
2016
406
0.210
 Why?
Practice Guidelines as Topic
2
2018
488
0.200
 Why?
Urethra
3
2014
98
0.190
 Why?
Prognosis
9
2021
2099
0.190
 Why?
Erectile Dysfunction
3
2023
93
0.190
 Why?
United States
12
2020
5192
0.190
 Why?
DNA, Neoplasm
2
2018
146
0.190
 Why?
Logistic Models
7
2021
925
0.190
 Why?
Vital Statistics
1
2021
3
0.180
 Why?
Feasibility Studies
2
2020
406
0.180
 Why?
Mandatory Reporting
1
2021
12
0.180
 Why?
Death Certificates
1
2021
18
0.180
 Why?
DNA Mutational Analysis
3
2018
180
0.180
 Why?
Birth Certificates
1
2021
26
0.180
 Why?
Cell Transdifferentiation
1
2021
8
0.180
 Why?
Cost-Benefit Analysis
2
2019
267
0.180
 Why?
Neuroendocrine Cells
1
2021
10
0.180
 Why?
Reproducibility of Results
7
2018
1229
0.180
 Why?
Urethral Diseases
2
2013
7
0.180
 Why?
Radiosurgery
1
2022
131
0.170
 Why?
Radiography, Abdominal
1
2020
25
0.170
 Why?
Reimbursement, Incentive
1
2020
12
0.170
 Why?
Mutation
5
2019
1347
0.170
 Why?
Genetic Vectors
1
2020
128
0.170
 Why?
Randomized Controlled Trials as Topic
4
2023
595
0.160
 Why?
Ablation Techniques
1
2019
21
0.160
 Why?
Genetic Therapy
1
2020
121
0.160
 Why?
Abdominal Pain
1
2020
85
0.160
 Why?
Diagnosis, Differential
2
2020
1046
0.160
 Why?
Venous Thromboembolism
1
2020
77
0.160
 Why?
Genetic Predisposition to Disease
5
2024
528
0.160
 Why?
Adjuvants, Immunologic
3
2024
52
0.150
 Why?
Urinary Tract
1
2018
25
0.150
 Why?
Forecasting
1
2019
154
0.150
 Why?
Predictive Value of Tests
6
2018
944
0.150
 Why?
Lymphocytes
1
2019
153
0.150
 Why?
Genetic Heterogeneity
1
2018
20
0.150
 Why?
Obesity
2
2006
1162
0.150
 Why?
RNA, Neoplasm
1
2018
45
0.150
 Why?
Patient-Centered Care
1
2020
141
0.150
 Why?
Neutrophils
1
2019
147
0.150
 Why?
Drug Resistance, Neoplasm
1
2020
326
0.150
 Why?
Programmed Cell Death 1 Receptor
1
2018
41
0.150
 Why?
Retroperitoneal Neoplasms
1
2018
18
0.140
 Why?
Orchiectomy
1
2018
38
0.140
 Why?
Internship and Residency
2
2021
448
0.140
 Why?
Transurethral Resection of Prostate
1
2018
10
0.140
 Why?
Pain, Postoperative
2
2016
169
0.140
 Why?
Body Size
1
2017
33
0.140
 Why?
Quality Assurance, Health Care
1
2018
149
0.140
 Why?
Physician-Patient Relations
2
2016
143
0.140
 Why?
Inguinal Canal
1
2017
11
0.140
 Why?
Urodynamics
2
2014
23
0.140
 Why?
Sarcosine
1
2017
3
0.140
 Why?
Amino Acid Transport Systems
1
2017
5
0.140
 Why?
Anticoagulants
1
2020
270
0.140
 Why?
Databases, Factual
2
2021
706
0.140
 Why?
Body Height
1
2017
66
0.140
 Why?
Electronic Health Records
1
2020
268
0.140
 Why?
Carbon Radioisotopes
1
2017
54
0.140
 Why?
Safety
1
2017
79
0.140
 Why?
Guidelines as Topic
1
2017
111
0.140
 Why?
Disease-Free Survival
5
2016
460
0.130
 Why?
Transcriptome
2
2018
370
0.130
 Why?
Replantation
1
2016
11
0.130
 Why?
Scrotum
2
2015
31
0.130
 Why?
Protons
1
2017
70
0.130
 Why?
Nomograms
1
2016
7
0.130
 Why?
Laparotomy
1
2016
37
0.130
 Why?
Natural Orifice Endoscopic Surgery
1
2016
5
0.130
 Why?
Research Report
1
2016
16
0.130
 Why?
Kaplan-Meier Estimate
5
2017
483
0.130
 Why?
Physicians
2
2016
241
0.130
 Why?
Urinary Retention
2
2007
7
0.130
 Why?
Patient Preference
1
2016
43
0.120
 Why?
Ureteral Obstruction
1
2016
62
0.120
 Why?
Checklist
1
2016
40
0.120
 Why?
Time-to-Treatment
1
2016
78
0.120
 Why?
Preoperative Period
3
2021
46
0.120
 Why?
Genital Neoplasms, Male
1
2015
2
0.120
 Why?
Paget Disease, Extramammary
1
2015
5
0.120
 Why?
Sensitivity and Specificity
5
2018
891
0.120
 Why?
Social Networking
1
2015
17
0.120
 Why?
Body Weight
1
2017
523
0.120
 Why?
Lymph Nodes
1
2017
258
0.120
 Why?
Feedback
1
2015
52
0.120
 Why?
Radiopharmaceuticals
1
2016
204
0.120
 Why?
Video Recording
1
2015
81
0.120
 Why?
Treatment Failure
2
2017
122
0.120
 Why?
Peer Group
1
2015
57
0.120
 Why?
Informed Consent
1
2015
95
0.110
 Why?
Papilloma, Inverted
1
2014
1
0.110
 Why?
Proto-Oncogene Proteins B-raf
1
2015
81
0.110
 Why?
Equipment Design
3
2021
293
0.110
 Why?
Computer Simulation
1
2015
290
0.110
 Why?
Proto-Oncogene Proteins p21(ras)
1
2014
69
0.110
 Why?
Blood Loss, Surgical
5
2016
71
0.110
 Why?
Matched-Pair Analysis
1
2013
11
0.110
 Why?
Urinary Incontinence, Stress
1
2014
32
0.110
 Why?
Kidney Diseases
1
2016
220
0.110
 Why?
Adenoma
1
2015
113
0.110
 Why?
Diffusion of Innovation
1
2013
47
0.110
 Why?
Carcinoma, Papillary
1
2014
51
0.110
 Why?
General Surgery
1
2015
105
0.110
 Why?
Body Mass Index
3
2020
689
0.110
 Why?
Technology Transfer
1
2013
2
0.110
 Why?
Mitomycin
1
2013
19
0.110
 Why?
Longitudinal Studies
2
2018
747
0.100
 Why?
Radiotherapy, Adjuvant
2
2018
63
0.100
 Why?
Accreditation
1
2013
62
0.100
 Why?
Severity of Illness Index
2
2014
1026
0.100
 Why?
Peripheral Nerves
1
2013
44
0.100
 Why?
Education, Medical, Continuing
1
2013
72
0.100
 Why?
Operating Rooms
1
2012
27
0.100
 Why?
Community Health Centers
1
2012
30
0.100
 Why?
Pathology, Clinical
1
2012
25
0.100
 Why?
Referral and Consultation
2
2012
292
0.100
 Why?
Receptors, Androgen
2
2002
46
0.100
 Why?
Algorithms
1
2015
672
0.090
 Why?
Combined Modality Therapy
3
2021
639
0.090
 Why?
Neoplasms
1
2021
1325
0.090
 Why?
Risk Factors
5
2017
3889
0.090
 Why?
Perioperative Care
1
2011
43
0.090
 Why?
Seminal Vesicles
2
2022
13
0.080
 Why?
Skin Neoplasms
1
2015
505
0.080
 Why?
Multicenter Studies as Topic
2
2023
105
0.080
 Why?
Phantoms, Imaging
2
2020
122
0.080
 Why?
Medicare
3
2020
274
0.080
 Why?
Proportional Hazards Models
3
2016
443
0.080
 Why?
Markov Chains
2
2019
30
0.080
 Why?
Carboplatin
2
2022
57
0.080
 Why?
SEER Program
3
2014
103
0.080
 Why?
Immunotherapy
1
2010
244
0.080
 Why?
Postoperative Care
2
2020
104
0.070
 Why?
Healthcare Disparities
1
2011
299
0.070
 Why?
Ureteroscopy
1
2007
10
0.070
 Why?
Automobiles
2
2017
13
0.070
 Why?
Pandemics
2
2023
585
0.070
 Why?
Sarcopenia
2
2021
98
0.070
 Why?
Chi-Square Distribution
3
2013
288
0.070
 Why?
Incidence
2
2021
1062
0.070
 Why?
Diverticulum
1
2007
21
0.070
 Why?
Peritoneum
1
2007
16
0.070
 Why?
Delphi Technique
2
2018
63
0.070
 Why?
Cisplatin
2
2022
285
0.070
 Why?
Gene Amplification
2
2018
58
0.070
 Why?
Aftercare
2
2018
76
0.070
 Why?
Societies, Medical
2
2018
200
0.070
 Why?
Adrenalectomy
1
2006
31
0.070
 Why?
Gene Expression Profiling
2
2024
1105
0.070
 Why?
Promoter Regions, Genetic
2
2019
467
0.060
 Why?
Postoperative Hemorrhage
1
2006
54
0.060
 Why?
Case-Control Studies
3
2014
1201
0.060
 Why?
Fibrin Tissue Adhesive
1
2005
12
0.060
 Why?
Sex Factors
2
2020
727
0.060
 Why?
Hand
1
2005
51
0.060
 Why?
Tissue Adhesives
1
2005
13
0.060
 Why?
Genomics
2
2018
268
0.060
 Why?
Intestines
1
2006
154
0.060
 Why?
Suture Techniques
1
2005
60
0.060
 Why?
Diabetes Complications
1
2005
122
0.060
 Why?
Renal Insufficiency
1
2005
113
0.060
 Why?
Chromosomes, Human, Pair 12
1
2024
14
0.060
 Why?
Glomerular Filtration Rate
2
2016
124
0.060
 Why?
Drug Screening Assays, Antitumor
1
2024
136
0.060
 Why?
Vulnerable Populations
1
2024
52
0.060
 Why?
Superior Mesenteric Artery Syndrome
1
2004
4
0.050
 Why?
Mediastinal Neoplasms
1
2024
18
0.050
 Why?
Communication
2
2016
257
0.050
 Why?
Intraoperative Complications
1
2005
112
0.050
 Why?
Hernia, Inguinal
1
2004
21
0.050
 Why?
Phenotype
2
2018
789
0.050
 Why?
High-Throughput Nucleotide Sequencing
2
2015
182
0.050
 Why?
Neoplasms, Second Primary
1
2024
77
0.050
 Why?
Cell Line, Tumor
2
2018
1470
0.050
 Why?
Child
3
2024
7248
0.050
 Why?
Quality of Health Care
2
2015
187
0.050
 Why?
Ischemia
1
2004
150
0.050
 Why?
Papillomavirus Infections
2
2015
173
0.050
 Why?
Perioperative Period
2
2013
22
0.050
 Why?
Trinucleotide Repeats
1
2002
4
0.050
 Why?
Chromosome Aberrations
1
2024
297
0.050
 Why?
Liver Cirrhosis
1
2005
240
0.050
 Why?
Muscles
1
2022
107
0.050
 Why?
Odds Ratio
2
2014
558
0.050
 Why?
Polymorphism, Restriction Fragment Length
1
2002
66
0.050
 Why?
Smoking
1
2005
520
0.050
 Why?
Gallium Isotopes
1
2021
2
0.050
 Why?
Accidents, Traffic
2
2017
90
0.050
 Why?
Gallium Radioisotopes
1
2021
10
0.050
 Why?
Edetic Acid
1
2021
14
0.050
 Why?
Androgen Antagonists
1
2021
11
0.050
 Why?
Geography
1
2021
65
0.050
 Why?
Radiotherapy, Intensity-Modulated
2
2013
184
0.050
 Why?
Quarantine
1
2021
12
0.050
 Why?
Polymorphism, Single Nucleotide
1
2024
505
0.050
 Why?
Public Health
1
2023
223
0.040
 Why?
Internationality
1
2021
43
0.040
 Why?
Neoplasm Metastasis
2
2017
243
0.040
 Why?
Drug Dosage Calculations
1
2020
11
0.040
 Why?
Motion
1
2020
19
0.040
 Why?
Enoxaparin
1
2020
31
0.040
 Why?
Finite Element Analysis
1
2020
12
0.040
 Why?
Drug Monitoring
1
2020
83
0.040
 Why?
Fellowships and Scholarships
1
2021
127
0.040
 Why?
Pelvis
1
2020
69
0.040
 Why?
DNA-Directed RNA Polymerases
1
2019
12
0.040
 Why?
Abdomen
1
2020
75
0.040
 Why?
Heparin
1
2020
88
0.040
 Why?
Young Adult
2
2024
4329
0.040
 Why?
Postoperative Period
1
2020
170
0.040
 Why?
Social Behavior
1
2019
74
0.040
 Why?
Urine
1
2018
25
0.040
 Why?
Cytodiagnosis
1
2018
43
0.040
 Why?
Adolescent
2
2024
6739
0.040
 Why?
Diagnostic Errors
1
2018
68
0.040
 Why?
Single-Blind Method
1
2018
116
0.040
 Why?
DNA Copy Number Variations
1
2018
117
0.040
 Why?
Quality-Adjusted Life Years
1
2018
66
0.040
 Why?
Genome, Human
1
2018
121
0.040
 Why?
Image Processing, Computer-Assisted
1
2019
253
0.040
 Why?
Sequence Analysis, RNA
1
2018
100
0.040
 Why?
Delivery of Health Care, Integrated
1
2018
49
0.030
 Why?
Random Allocation
1
2018
285
0.030
 Why?
Health Services Accessibility
2
2012
436
0.030
 Why?
Hospitalization
2
2017
736
0.030
 Why?
Nephrons
1
2016
6
0.030
 Why?
Tissue Distribution
1
2017
171
0.030
 Why?
Dose-Response Relationship, Drug
1
2020
1378
0.030
 Why?
Consensus
1
2018
181
0.030
 Why?
Hospital Communication Systems
1
2016
5
0.030
 Why?
Coitus
1
2016
18
0.030
 Why?
Failure to Thrive
1
2016
19
0.030
 Why?
Anastomosis, Surgical
1
2016
68
0.030
 Why?
Salvage Therapy
1
2017
136
0.030
 Why?
Creatinine
1
2016
150
0.030
 Why?
Radiometry
1
2017
127
0.030
 Why?
Cyclin-Dependent Kinase 4
1
2015
10
0.030
 Why?
Early Detection of Cancer
1
2018
189
0.030
 Why?
Multiplex Polymerase Chain Reaction
1
2015
13
0.030
 Why?
Genes, erbB-1
1
2015
9
0.030
 Why?
Operative Time
1
2016
77
0.030
 Why?
Tape Recording
1
2015
7
0.030
 Why?
Fever
1
2016
112
0.030
 Why?
Molecular Imaging
1
2016
55
0.030
 Why?
Learning Curve
1
2015
19
0.030
 Why?
Socioeconomic Factors
2
2011
610
0.030
 Why?
Groin
1
2015
16
0.030
 Why?
Tissue Array Analysis
1
2015
46
0.030
 Why?
Oncology Service, Hospital
1
2014
14
0.030
 Why?
Clinical Trials, Phase III as Topic
1
2015
48
0.030
 Why?
Vinblastine
1
2014
23
0.030
 Why?
Europe
1
2014
87
0.030
 Why?
North America
1
2014
73
0.030
 Why?
Regression Analysis
1
2015
401
0.030
 Why?
Incontinence Pads
1
2014
2
0.030
 Why?
In Situ Hybridization
1
2014
64
0.030
 Why?
Amino Acid Substitution
1
2014
82
0.030
 Why?
Personal Satisfaction
1
2014
75
0.030
 Why?
Kidney Failure, Chronic
1
2016
210
0.030
 Why?
Gene Dosage
1
2014
78
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2018
857
0.030
 Why?
Methotrexate
1
2014
77
0.030
 Why?
Ultrasonography
1
2016
430
0.030
 Why?
United States Department of Veterans Affairs
1
2015
293
0.030
 Why?
Papillomaviridae
1
2014
105
0.030
 Why?
Survivors
1
2014
120
0.030
 Why?
Anxiety
1
2016
300
0.030
 Why?
Dysuria
1
2013
1
0.030
 Why?
Cluster Analysis
1
2014
233
0.030
 Why?
Anesthesiology
1
2014
44
0.030
 Why?
Intention to Treat Analysis
1
2013
30
0.030
 Why?
Prevalence
1
2016
1006
0.030
 Why?
Sequence Analysis, DNA
1
2014
229
0.030
 Why?
Valsalva Maneuver
1
2013
10
0.030
 Why?
Stents
1
2016
351
0.030
 Why?
Diagnostic Tests, Routine
1
2013
31
0.030
 Why?
Paclitaxel
1
2013
89
0.030
 Why?
Health Services Research
1
2013
153
0.030
 Why?
Doxorubicin
1
2014
241
0.030
 Why?
Confidence Intervals
1
2013
158
0.020
 Why?
Antibiotics, Antineoplastic
1
2013
80
0.020
 Why?
Neutropenia
1
2013
115
0.020
 Why?
Thrombocytopenia
1
2013
89
0.020
 Why?
Survival Analysis
1
2014
673
0.020
 Why?
Angiomyolipoma
1
2012
10
0.020
 Why?
Attitude of Health Personnel
1
2015
360
0.020
 Why?
Unnecessary Procedures
1
2012
20
0.020
 Why?
Neoplasm, Residual
1
2013
173
0.020
 Why?
Tertiary Care Centers
1
2012
85
0.020
 Why?
Pilot Projects
1
2014
721
0.020
 Why?
Neoplasms, Multiple Primary
1
2012
44
0.020
 Why?
Biopsy, Fine-Needle
1
2012
107
0.020
 Why?
Patient Positioning
1
2011
32
0.020
 Why?
Urination Disorders
1
2010
23
0.020
 Why?
Disease Management
1
2012
188
0.020
 Why?
Organ Size
1
2010
228
0.020
 Why?
Comorbidity
1
2012
625
0.020
 Why?
Health Status Disparities
1
2011
215
0.020
 Why?
Intraoperative Period
1
2007
46
0.020
 Why?
Erythrocyte Transfusion
1
2006
52
0.020
 Why?
Costs and Cost Analysis
1
2006
95
0.020
 Why?
Decision Trees
1
2005
22
0.020
 Why?
Portal System
1
2005
17
0.010
 Why?
Collateral Circulation
1
2005
38
0.010
 Why?
Hypertension, Portal
1
2005
21
0.010
 Why?
Reoperation
1
2006
465
0.010
 Why?
Blood Transfusion
1
2005
127
0.010
 Why?
Short Bowel Syndrome
1
2004
17
0.010
 Why?
Necrosis
1
2004
176
0.010
 Why?
Liver Transplantation
1
2005
165
0.010
 Why?
Polymorphism, Genetic
1
2002
185
0.010
 Why?
Genetic Markers
1
2002
109
0.010
 Why?
Statistics, Nonparametric
1
2002
192
0.010
 Why?
Base Sequence
1
2002
640
0.010
 Why?
Polymerase Chain Reaction
1
2002
461
0.010
 Why?
Molecular Sequence Data
1
2002
778
0.010
 Why?
Montgomery's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (437) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (28) people
_
Same Department Expand Description
Search Department